Novo Nordisk A/S - Hax
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Denmark
- Registered address
- Hagedornsvej 1, Gentofte, Hovedstaden 2820, Denmark (DNK)
- Operations here
- analysisapi manufacturelabelmanufacturepack
- FDA identifiers
- FEI 3002807748 · DUNS 306711800
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-06-01
- NAIDrug Quality Assurance2018-05-08
- NAIDrug Quality Assurance2016-06-14
- VAIBlood and Blood Products2015-11-06
- VAIDrug Quality Assurance2014-05-13
- VAIBlood and Blood Products2013-05-01
- VAIDrug Quality Assurance2012-06-26
- VAIBlood and Blood Products2011-02-17
- VAIDrug Quality Assurance2009-03-06
- VAIHuman Cellular, Tissue, and Gene Therapies2009-03-05
Drugs this plant is listed as making
2 distinct drugs across 5 products name this site in their FDA label.
- liraglutidein shortageNovo Nordisk Pharmaceutical Industries, LP
- somatropinNovo Nordisk
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.